Cell, tissue and gene therapy (CTGT) involves the introduction of whole genetically- or non-genetically modified cells into a patient to carry out an immunotherapeutic or regenerative function to treat diseases and/or damaged organs. CTGT as witnessed by the regulatory approval of several life-savin...See more
Headquarters:
Singapore
Company Type:
SME
Company size:
51-200 Employees
Year Founded:
2020 (6 years)
Address:
SINGAPORE, SG
LOW
spending power